Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $35.5300 (-8.99%) ($35.5300 - $35.5300) on Fri. Oct. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.26% (three month average) | RSI | 11 | Latest Price | $35.5300(-8.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -20.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(68%) IWO(63%) IBUY(61%) IWC(61%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.63% in a week (0% probabilities). VIXM(-32%) UUP(-16%) VXX(-12%) TBT(-8%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.63% (StdDev 5.26%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $7.04(-80.19%) | Resistance Level | $50.88 | 5 Day Moving Average | $37.56(-5.4%) | 10 Day Moving Average | $41.77(-14.94%) | 20 Day Moving Average | $50.88(-30.17%) | To recent high | -51.2% | To recent low | 0% | Market Cap | $2.207b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |